Authors: ALDEGHI R LISSONI P BARNI S ARDIZZOIA A TANCINI G PIPERNO A POZZI M RICCI G CONTI A MAESTRONI GJM

Citation: R. Aldeghi et al., LOW-DOSE INTERLEUKIN-2 SUBCUTANEOUS IMMUNOTHERAPY IN ASSOCIATION WITHTHE PINEAL HORMONE MELATONIN AS A FIRST-LINE THERAPY IN LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR-CARCINOMA, European journal of cancer, 30A(2), 1994, pp. 167-170

Authors: LISSONI P BARNI S TANCINI G ARDIZZOIA A RICCI G ALDEGHI R BRIVIO F TISI E ROVELLI F RESCALDANI R QUADRO G MAESTRONI G

Citation: P. Lissoni et al., A RANDOMIZED STUDY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 ALONE VS INTERLEUKIN-2 PLUS THE PINEAL NEUROHORMONE MELATONIN IN ADVANCED SOLIDNEOPLASMS OTHER THAN RENAL-CANCER AND MELANOMA, British Journal of Cancer, 69(1), 1994, pp. 196-199

Authors: LISSONI P BARNI S TANCINI G ARDIZZOIA A ROVELLI F CAZZANIGA M BRIVIO F PIPERNO A ALDEGHI R FOSSATI D CHARACIEJUS D KOTHARI L CONTI A MAESTRONI GJM

Citation: P. Lissoni et al., IMMUNOTHERAPY WITH SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 AND THE PINEALINDOLE MELATONIN AS A NEW EFFECTIVE THERAPY IN ADVANCED CANCERS OF THE DIGESTIVE-TRACT, British Journal of Cancer, 67(6), 1993, pp. 1404-1407